This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Friday, October 21, 2016
Future role of gastroenterologists in HCV therapy
LAS VEGAS — In this exclusive video from ACG 2016, Tram T. Tran, MD, FACG, medical director of liver transplantation, Liver Disease and Transplant Center, Cedars-Sinai, Los Angeles, discusses the role of gastroenterologists in future hepatitis C virus treatment, and how they will play a role in assisting primary care physicians in treatment
Read more...
ACG American College of Gastroenterology
October 14, 2016 - October 19, 2016
Meeting Coverage
Healio brings you the highlights from the American College of Gastroenterology Annual Scientific Meeting. Refer back to this page often for the latest news from ACG, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
No comments:
Post a Comment